136 related articles for article (PubMed ID: 33912512)
1. Enhanced inhibition of tumor growth using TRAIL-overexpressing adipose-derived stem cells in combination with the chemotherapeutic agent CPT-11 in castration-resistant prostate cancer.
Kim JH; Oh E; Han YS; Lee SH; Song YS
Prostate Int; 2021 Mar; 9(1):31-41. PubMed ID: 33912512
[TBL] [Abstract][Full Text] [Related]
2. Carboxylesterase-overexpressing hTERT-immortalized human adipose stem cells in prostate tumor growth inhibition by irinotecan.
Kim JH; Oh E; Song ES; Yun CW; Lee SH; Song YS
J Cancer Res Ther; 2023 Oct; 19(7):1731-1742. PubMed ID: 38376272
[TBL] [Abstract][Full Text] [Related]
3. Carboxyl Esterase-TRAIL Expressing Human Adipose Stem Cells Inhibit Tumor Growth in Castration-Resistant Prostate Cancer-Bearing Mice with Less Toxicity.
Kim JH; Oh E; Yun CW; Lee SH; Song YS
Technol Cancer Res Treat; 2022; 21():15330338221093146. PubMed ID: 35491733
[TBL] [Abstract][Full Text] [Related]
4. Cytosine Deaminase-Overexpressing hTERT-Immortalized Human Adipose Stem Cells Enhance the Inhibitory Effects of Fluorocytosine on Tumor Growth in Castration Resistant Prostate Cancer.
Kim JH; Yang HJ; Lee SH; Song YS
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791557
[TBL] [Abstract][Full Text] [Related]
5. Secreted TRAIL gene-modified adipose-derived stem cells exhibited potent tumor-suppressive effect in hepatocellular carcinoma cells.
Liu Z; Li S; Ma T; Zeng J; Zhou X; Li H; Tang M; Liu X; Li F; Jiang B; Zhao M; Chen Y
Immun Inflamm Dis; 2021 Mar; 9(1):144-156. PubMed ID: 33156578
[TBL] [Abstract][Full Text] [Related]
6. Anti-Cancer Effect of Neural Stem Cells Transfected with Carboxylesterase and sTRAIL Genes in Animals with Brain Lesions of Lung Cancer.
Kim JH; Ahn JS; Lee DS; Hong SH; Lee HJ
Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631070
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous inhibition of epidermal growth factor receptor (EGFR) signaling and enhanced activation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-mediated apoptosis induction by an scFv:sTRAIL fusion protein with specificity for human EGFR.
Bremer E; Samplonius DF; van Genne L; Dijkstra MH; Kroesen BJ; de Leij LF; Helfrich W
J Biol Chem; 2005 Mar; 280(11):10025-33. PubMed ID: 15644326
[TBL] [Abstract][Full Text] [Related]
8. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
Yoo J; Choi S; Hwang KS; Cho WK; Jung CR; Kwon ST; Im DS
J Gene Med; 2006 Feb; 8(2):163-74. PubMed ID: 16144019
[TBL] [Abstract][Full Text] [Related]
9. Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects.
Yu R; Deedigan L; Albarenque SM; Mohr A; Zwacka RM
Cell Death Dis; 2013 Feb; 4(2):e503. PubMed ID: 23429289
[TBL] [Abstract][Full Text] [Related]
10. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin].
He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhang BX
Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):453-7. PubMed ID: 12895357
[TBL] [Abstract][Full Text] [Related]
11. [Adeno-associated virus mediated tumor necrosis factor related apoptosis inducing ligand gene transfected into hepatocellular carcinoma cells by ultrasound microbubble intensifier: an experimental study].
Xia JT; Xu B; Wang SC; Lai YY; Wu ZF; Li SH; Li W
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1846-50. PubMed ID: 19040022
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts.
El-Zawahry A; McKillop J; Voelkel-Johnson C
BMC Cancer; 2005 Jan; 5():2. PubMed ID: 15638938
[TBL] [Abstract][Full Text] [Related]
13. Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells.
Mohr A; Albarenque SM; Deedigan L; Yu R; Reidy M; Fulda S; Zwacka RM
Stem Cells; 2010 Nov; 28(11):2109-20. PubMed ID: 20882532
[TBL] [Abstract][Full Text] [Related]
14. The scavenging of superoxide radicals promotes apoptosis induced by a novel cell-permeable fusion protein, sTRAIL:FeSOD, in tumor necrosis factor-related apoptosis-inducing ligand-resistant leukemia cells.
Tang H; Qin Y; Li J; Gong X
BMC Biol; 2011 Mar; 9():18. PubMed ID: 21418589
[TBL] [Abstract][Full Text] [Related]
15. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11.
Gliniak B; Le T
Cancer Res; 1999 Dec; 59(24):6153-8. PubMed ID: 10626806
[TBL] [Abstract][Full Text] [Related]
17. Effects of transplantation of adipose tissue-derived stem cells on prostate tumor.
Lin G; Yang R; Banie L; Wang G; Ning H; Li LC; Lue TF; Lin CS
Prostate; 2010 Jul; 70(10):1066-73. PubMed ID: 20232361
[TBL] [Abstract][Full Text] [Related]
18. Exosomes derived from adipose-derived stem cells overexpressing glyoxalase-1 protect endothelial cells and enhance angiogenesis in type 2 diabetic mice with limb ischemia.
Zhang X; Jiang Y; Huang Q; Wu Z; Pu H; Xu Z; Li B; Lu X; Yang X; Qin J; Peng Z
Stem Cell Res Ther; 2021 Jul; 12(1):403. PubMed ID: 34266474
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells.
Bremer E; de Bruyn M; Samplonius DF; Bijma T; ten Cate B; de Leij LF; Helfrich W
J Mol Med (Berl); 2008 Aug; 86(8):909-24. PubMed ID: 18504532
[TBL] [Abstract][Full Text] [Related]
20. Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells.
Liu X; Wang J; Wang H; Liu S; Liang Y; Lv Z; Zhou Q; Ding W
Oncol Rep; 2013 Oct; 30(4):1913-9. PubMed ID: 23912708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
